Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 23, 2023
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
[ Fri, Jun 23rd 2023
] - WOPRAI
Thu, June 22, 2023
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
[ Thu, Jun 22nd 2023
] - WOPRAI
Ed Arce Reiterated (ABUS) at Strong Buy and Held Target at $6 on, Jun 22nd, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Arbutus Biopharma Corporation" (ABUS) at Strong Buy and Held Target at $6 on, Jun 22nd, 2023.
Ed has made no other calls on ABUS in the last 4 months.
There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Roy Buchanan of "JMP Securities" Reiterated at Buy and Held Target at $6 on, Wednesday, March 29th, 2023
